Personal
Become a Client
22nd Century Group Inc (USD)
XXII
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range3.50 | 3.77
52-Wk Range- | -
Last Close3.61
Mkt Cap (m)550.15
Dividend yield-
ISINUS90137F1030
Volume1,289,832.00
Exchange VenueASE

Company Profile

22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

Key Information
Price/Earning-
Price/Book12.47
Price/Sales17.83
P/CF-
Rev Growth (3 year avg)19.19
EPS Growth (3 year avg)-
Operating Margin % -67.61
Net Margin %-70.12
Return on Equity-37.13
Debt/Equity0.02

Documents

Prospectus
en 23/12/2019
Annual Report
en 31/12/2020

Please refer to the below issuer website for further documents.

https://www.xxiicentury.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)8.5212.2816.6026.4325.8328.11
Operating Income (m)-12.04-11.39-13.30-24.02-22.42-19.01
Net Income (m)-11.03-11.58-13.03-7.97-26.56-19.71
Basic EPS-0.16-0.15-0.13-0.06-0.21-0.14
Avg. Diluted Shares Outstanding (m)68.1479.84101.16124.30125.88138.81
Balance Sheet
USD201520162017201820192020
Current Assets (m)7.2316.8067.6261.2042.7428.34
Non Current Assets (m)11.1410.8412.1216.1026.2123.35
Total Assets (m)18.3727.6479.7477.3068.9551.69
Current Liabilities (m)3.243.254.315.175.787.34
Total Liabilities (m)------
Total Equity (m)11.7324.3375.4371.2862.0544.11
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-7.32-9.89-12.07-17.84-14.59-15.62
Capital Expenditure (m)-0.45-0.55-1.61-1.11-1.09-0.52
Figures are quoted in USD unless stated otherwise
-
No change
$
3.61
Last Price